These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 11839581)
1. Quantitative assessment of promoter hypermethylation during breast cancer development. Lehmann U; Länger F; Feist H; Glöckner S; Hasemeier B; Kreipe H Am J Pathol; 2002 Feb; 160(2):605-12. PubMed ID: 11839581 [TBL] [Abstract][Full Text] [Related]
2. Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer. Umbricht CB; Evron E; Gabrielson E; Ferguson A; Marks J; Sukumar S Oncogene; 2001 Jun; 20(26):3348-53. PubMed ID: 11423985 [TBL] [Abstract][Full Text] [Related]
3. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions. Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681 [TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients. Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006 [TBL] [Abstract][Full Text] [Related]
5. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma. Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038 [TBL] [Abstract][Full Text] [Related]
6. Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients. Honorio S; Agathanggelou A; Schuermann M; Pankow W; Viacava P; Maher ER; Latif F Oncogene; 2003 Jan; 22(1):147-50. PubMed ID: 12527916 [TBL] [Abstract][Full Text] [Related]
8. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Belinsky SA; Palmisano WA; Gilliland FD; Crooks LA; Divine KK; Winters SA; Grimes MJ; Harms HJ; Tellez CS; Smith TM; Moots PP; Lechner JF; Stidley CA; Crowell RE Cancer Res; 2002 Apr; 62(8):2370-7. PubMed ID: 11956099 [TBL] [Abstract][Full Text] [Related]
9. Epigenetic progression of columnar cell lesions of the breast to invasive breast cancer. Verschuur-Maes AH; de Bruin PC; van Diest PJ Breast Cancer Res Treat; 2012 Dec; 136(3):705-15. PubMed ID: 23104224 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic alterations by methylation of RASSF1A and DAPK1 promoter sequences in mammary carcinoma detected in extracellular tumor DNA. Ahmed IA; Pusch CM; Hamed T; Rashad H; Idris A; El-Fadle AA; Blin N Cancer Genet Cytogenet; 2010 Jun; 199(2):96-100. PubMed ID: 20471512 [TBL] [Abstract][Full Text] [Related]
11. Detection of tumor markers including carcinoembryonic antigen, APC, and cyclin D2 in fine-needle aspiration fluid of breast. Lee A; Kim Y; Han K; Kang CS; Jeon HM; Shim SI Arch Pathol Lab Med; 2004 Nov; 128(11):1251-6. PubMed ID: 15508191 [TBL] [Abstract][Full Text] [Related]
12. Promoter hypermethylation of the death-associated protein kinase gene in breast cancer is associated with the invasive lobular subtype. Lehmann U; Celikkaya G; Hasemeier B; Länger F; Kreipe H Cancer Res; 2002 Nov; 62(22):6634-8. PubMed ID: 12438260 [TBL] [Abstract][Full Text] [Related]
13. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Kwong J; Lo KW; To KF; Teo PM; Johnson PJ; Huang DP Clin Cancer Res; 2002 Jan; 8(1):131-7. PubMed ID: 11801549 [TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk. Lewis CM; Cler LR; Bu DW; Zöchbauer-Müller S; Milchgrub S; Naftalis EZ; Leitch AM; Minna JD; Euhus DM Clin Cancer Res; 2005 Jan; 11(1):166-72. PubMed ID: 15671542 [TBL] [Abstract][Full Text] [Related]
15. [Epigenetic changes in breast cancer shown by aberrant promoter methylation]. Lehmann U; Länger F; Celikkaya G; Lück HJ; Kreipe H Zentralbl Gynakol; 2004 Aug; 126(4):272-4. PubMed ID: 15389379 [TBL] [Abstract][Full Text] [Related]
16. Patterns of gene promoter methylation in squamous cell cancer of the head and neck. Hasegawa M; Nelson HH; Peters E; Ringstrom E; Posner M; Kelsey KT Oncogene; 2002 Jun; 21(27):4231-6. PubMed ID: 12082610 [TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients. Sharma G; Mirza S; Prasad CP; Srivastava A; Gupta SD; Ralhan R Life Sci; 2007 Apr; 80(20):1873-81. PubMed ID: 17383681 [TBL] [Abstract][Full Text] [Related]
18. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects. Hoque MO; Topaloglu O; Begum S; Henrique R; Rosenbaum E; Van Criekinge W; Westra WH; Sidransky D J Clin Oncol; 2005 Sep; 23(27):6569-75. PubMed ID: 16170165 [TBL] [Abstract][Full Text] [Related]
19. Methylation of CpG islands of p16(INK4a) and cyclinD1 overexpression associated with progression of intraductal proliferative lesions of the breast. Liu T; Niu Y; Feng Y; Niu R; Yu Y; Lv A; Yang Y Hum Pathol; 2008 Nov; 39(11):1637-46. PubMed ID: 18657295 [TBL] [Abstract][Full Text] [Related]
20. [Methylation status and protein expression of adenomatous polyposis coli (APC) gene in breast cancer]. Liu Z; Yang L; Cui DX; Liu BL; Zhang XB; Ma WF; Zhang Q Ai Zheng; 2007 Jun; 26(6):586-90. PubMed ID: 17562262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]